# Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus

> **NCT01645332** · PHASE3 · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 104 (actual)

## Conditions studied

- Type-2-diabetes Mellitus
- New Onset

## Interventions

- **DRUG:** Placebo of DLBS3233
- **DRUG:** DLBS3233
- **OTHER:** Lifestyle modification

## Key facts

- **NCT ID:** NCT01645332
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2014-08
- **Final completion:** 2014-09
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2014-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01645332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01645332, "Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01645332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*